Sun Pharma says it could be a few more quarters before it resolves FDA concerns over its key plant in Halol, a situation that continues to be a drag on its…

India’s Aurobindo has acquired four biosimilar products from a Swiss company and says it is building a manufacturing plant to support the production of those…

Eli Lilly is rethinking plans to add a manufacturing line to a plant in Ireland following President Trump’s call on drugmakers to invest in the U.S.

It is a reversal of fortunes for a Pfizer plant in Australia. The U.S. drugmaker has decided to close the facility and lay off nearly 90 workers after…

Dr. Reddy’s Laboratories said regulatory problems with its substitute supplier may keep it from getting to market this quarter with a generic of blockbuster…

WuXi AppTec subsidiary STA has bulked up with a new pilot plant and a fresh batch of R&D scientists trained at the company’s Shanghai R&D site.

New Jersey-based CDMO Catalent grew its revenues in the second quarter but saw a significant fall in net earnings, but still beat analysts forecasts. It has…

India’s Strides Shasun has decided to radically remake itself, focusing on a consumer formulations business it will call Strides Pharma and spinning or selling…

Dublin-base Alkermes intends to increase capacity and add nearly 100 jobs to the Ohio plant that manufactures its opioid abuse drug Vivitrol.

Supply Chain